ORY-1001 Phase 1 Data At ASH In AL Looks Good For Oryzon, Roche

Oryzon is focused on developing epigenetic-based therapies and personalized drugs from its proprietary platform technology. Oryzon currently trades on the Madrid Stock Exchange with a market capitalization of approximately €145 million.